236 related articles for article (PubMed ID: 7841457)
1. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress. An early phenomenon characteristic of acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
Int J Pancreatol; 1992 Dec; 12(3):193-9. PubMed ID: 1289414
[TBL] [Abstract][Full Text] [Related]
3. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
[TBL] [Abstract][Full Text] [Related]
4. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
5. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
8. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
9. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.
Dabrowski A; Gabryelewicz A; Chyczewski L
Int J Pancreatol; 1995 Apr; 17(2):173-80. PubMed ID: 7542692
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of gabexate mesilate (FOY) against pancreatic injuries induced by ethanol in rats.
Hirano T
Nihon Geka Hokan; 1994 Jan; 63(1):10-20. PubMed ID: 7826181
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
Scand J Gastroenterol; 1994 Oct; 29(10):943-8. PubMed ID: 7530859
[TBL] [Abstract][Full Text] [Related]
12. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
[TBL] [Abstract][Full Text] [Related]
13. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
15. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
Chen HM; Shyr MH; Chen MF
J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
[TBL] [Abstract][Full Text] [Related]
16. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
18. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.
Yagci G; Gul H; Simsek A; Buyukdogan V; Onguru O; Zeybek N; Aydin A; Balkan M; Yildiz O; Sen D
J Gastroenterol; 2004; 39(3):268-76. PubMed ID: 15065005
[TBL] [Abstract][Full Text] [Related]
20. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
